Black Diamond Therapeutics, Inc. (BDTX)
2.33
+0.03
(+1.30%)
USD |
NASDAQ |
Feb 20, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics Market Cap : 132.75M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bionano Genomics, Inc. | 11.60M |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
| Savara, Inc. | 1.125B |
| BioMarin Pharmaceutical, Inc. | 12.31B |
Market Cap Related Metrics
| PE Ratio | 6.422 |
| PS Ratio | 1.897 |
| Price to Book Value | 1.052 |
| Price to Free Cash Flow | 6.222 |
| Price | 2.33 |
| Earnings Yield | 15.57% |
| Operating PE Ratio | 11.20 |
| Normalized PE Ratio | 6.422 |